Live from the NIH registry
Studies recruiting near Frederick right now
Top 25 of 258 recruiting studies, sorted by proximity — each links to its official registry page
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Kaiser Permanente-Gaithersburg Medical Center — Gaithersburg, Maryland (23.1 mi)
· Sponsor: SWOG Cancer Research Network
Efficacy of Buprenorphine and XR-Naltrexone Combination for Relapse Prevention in Opioid Use Disorder
Opioid-use Disorder
Phase 2, Phase 3
Interventional 180 participants sought
Avery Road Treatment Center (ARTC) — Rockville, Maryland (27.9 mi)
· Sponsor: New York State Psychiatric Institute
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
Phase 3
Interventional 450 participants sought
Sl0044 50730 — Rockville, Maryland (27.9 mi)
· Sponsor: UCB Biopharma SRL
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Percutaneous Coronary Intervention, Peripheral Endovascular Intervention
Phase 4
Interventional 6,000 participants sought
Shady Grove Adventist Hospital — Rockville, Maryland (27.9 mi)
· Sponsor: Duke University
A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
PARKINSON DISEASE (Disorder)
Phase 2
Interventional 80 participants sought
Vima Site #007 — Olney, Maryland (26.8 mi)
· Sponsor: Vima Therapeutics
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
WVUH-Berkely Medical Center — Martinsburg, West Virginia (29.4 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Secukinumab Open Label Roll-over Extension Protocol
Autoimmunity, Inflammation
Phase 4
Interventional 1,000 participants sought
Klein and Associates — Hagerstown, Maryland (21.7 mi)
· Sponsor: Novartis Pharmaceuticals
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8
Phase 3
Interventional 1,209 participants sought
Adams Cancer Center — Gettysburg, Pennsylvania (29.1 mi)
· Sponsor: NRG Oncology
A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia
Schizophrenia
Phase 2
Interventional 268 participants sought
Cbh Health - Gaithersburg /ID# 272932 — Gaithersburg, Maryland (23.1 mi)
· Sponsor: AbbVie
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Type 2 Diabetes, Cortisol Excess
Phase 2
Interventional 1,500 participants sought
Velocity Clinical Research, Rockville — Rockville, Maryland (27.9 mi)
· Sponsor: Sparrow Pharmaceuticals
A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
Major Depressive Disorder (MDD)
Phase 2
Interventional 300 participants sought
Draig Clinical Site — Gaithersburg, Maryland (23.1 mi)
· Sponsor: Draig Therapeutics Ltd
WellSpan-THRIVE Cancer QOL Study
Cancer (Active Cancer, Meaning Not Being Cancer Free), of Any Stage and Involving Any Treatment/Care Regimen; i.e. Curative, Life-extending, or Palliative, Cancer (Solid Tumors)
N/A
Observational 1,000 participants sought
WellSpan Adams Cancer Center — Gettysburg, Pennsylvania (29.1 mi)
· Sponsor: WellSpan Health
Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema
Diabetic Retinopathy
Phase 2, Phase 3
Interventional 576 participants sought
Mid Atlantic Retina Specialists - Hagerstown /ID# 274725 — Hagerstown, Maryland (21.7 mi)
· Sponsor: AbbVie
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
Hematopoietic and Lymphoid Cell Neoplasm, Immune System Disorder
N/A
Observational 2,240 participants sought
Adams Cancer Center — Gettysburg, Pennsylvania (29.1 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
C-Brace Prospective Registry
Pareses, Lower Extremity
N/A
Observational 250 participants sought
Ability x Ottobock.care — Frederick, Maryland (1.4 mi)
· Sponsor: Otto Bock Healthcare Products GmbH
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Locally Advanced Lung Non-Small Cell Carcinoma, Stage IIB Lung Cancer AJCC v8
Phase 3
Interventional 474 participants sought
William E Kahlert Regional Cancer Center/Sinai Hospital — Westminster, Maryland (24.4 mi)
· Sponsor: NRG Oncology
Testicular Evaluation of Azoospermia Using Micro-Ultrasound
Azoospermia
N/A
Observational 40 participants sought
Shady Grove Fertility — Rockville, Maryland (27.9 mi)
· Sponsor: Paul Shin
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
Pulmonary Disease, Chronic Obstructive
Phase 3
Interventional 961 participants sought
GSK Investigational Site — Rockville, Maryland (27.9 mi)
· Sponsor: GlaxoSmithKline
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Breast Cancer
Phase 3
Interventional 3,960 participants sought
Frederick Memorial Hospital — Frederick, Maryland (1.4 mi)
· Sponsor: NRG Oncology
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
Multiple conditions
Phase 2
Interventional 98 participants sought
Adams Cancer Center — Gettysburg, Pennsylvania (29.1 mi)
· Sponsor: NRG Oncology
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
Psoriatic Arthritis
Phase 3
Interventional 1,088 participants sought
Klein & Associates, M.D., P.A. — Hagerstown, Maryland (21.7 mi)
· Sponsor: Takeda
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Atherosclerotic Cardiovascular Disease, Overweight
Phase 3
Interventional 12,800 participants sought
Velocity Clinical Research - Rockville — Rockville, Maryland (27.9 mi)
· Sponsor: Amgen
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Malignant Solid Neoplasm
N/A
Observational 2,062 participants sought
William E Kahlert Regional Cancer Center/Sinai Hospital — Westminster, Maryland (24.4 mi)
· Sponsor: SWOG Cancer Research Network
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
NonSegmental Vitiligo
Phase 3
Interventional 180 participants sought
Dermatology Associates Pc — Rockville, Maryland (27.9 mi)
· Sponsor: Incyte Corporation
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Colorectal Neoplasms
Phase 3
Interventional 1,000 participants sought
Frederick Health Hospital - James M Stockman Cancer Institute — Frederick, Maryland (1.4 mi)
· Sponsor: Janssen Research & Development, LLC